These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39373375)

  • 21. Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology.
    Arnone M; Takahashi MDF; Carvalho AVE; Bernardo WM; Bressan AL; Ramos AMC; Terena AC; Souza CDS; Nunes DH; Bortoletto MCC; Oliveira MFSP; Neffá JM; Fieri LC; Azulay-Abulafia L; Felix PAO; Magalhaes RF; Romiti R; Jaime TJ
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):76-107. PubMed ID: 31166402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center.
    Heinecke GM; Luber AJ; Levitt JO; Lebwohl MG
    J Drugs Dermatol; 2013 Oct; 12(10):1098-102. PubMed ID: 24085044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2022 May; 5(5):CD011535. PubMed ID: 35603936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents.
    Ighani A; Partridge ACR; Shear NH; Lynde C; Gulliver WP; Sibbald C; Fleming P
    J Cutan Med Surg; 2019; 23(2):204-221. PubMed ID: 30463416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of severe psoriasis in children: recommendations of an Italian expert group.
    Fortina AB; Bardazzi F; Berti S; Carnevale C; Di Lernia V; El Hachem M; Neri I; Gelmetti CM; Lora V; Mazzatenta C; Milioto M; Moretta G; Patrizi A; Peris K; Villani A
    Eur J Pediatr; 2017 Oct; 176(10):1339-1354. PubMed ID: 28836064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis SOLAPSO - Sociedad Latinoamericana de Psoriasis (Latin American Psoriasis Society).
    Kogan N; Raimondo N; Gusis SE; Izcovich A; Abarca Duran JA; Barahona-Torres L; Blanco O; Quintana GB; Briones MC; Castro C; Castro Vargas EG; Criniti J; Diez de Medina JC; Franco M; Gómez M; Levrero VP; Martínez López JE; Valenzuela F
    Int J Dermatol; 2019 Aug; 58 Suppl 1():4-28. PubMed ID: 31282026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation.
    Grozdev IS; Van Voorhees AS; Gottlieb AB; Hsu S; Lebwohl MG; Bebo BF; Korman NJ;
    J Am Acad Dermatol; 2011 Sep; 65(3):537-545. PubMed ID: 21496950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users.
    Ighani A; Yu AM; Sandhu VK; Barankin B; Manolson MF
    J Cutan Med Surg; 2019; 23(2):148-156. PubMed ID: 30801221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in Psoriasis.
    Smith J; Cline A; Feldman SR
    South Med J; 2017 Jan; 110(1):65-75. PubMed ID: 28052180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching-adjusted indirect comparison.
    Bewley AP; Shear NH; Calzavara-Pinton PG; Hansen JB; Nyeland ME; Signorovitch J
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):1107-1115. PubMed ID: 30472749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Essential Truths for the Care and Management of Moderate-to-Severe Psoriasis.
    Blauvelt A; Armstrong AW; Krueger GG
    J Drugs Dermatol; 2015 Aug; 14(8):805-12. PubMed ID: 26267724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Guelimi R; Garcia-Doval I; Hua C; Hughes C; Naldi L; Kinberger M; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011535. PubMed ID: 37436070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.
    Gelfand JM; Wan J; Callis Duffin K; Krueger GG; Kalb RE; Weisman JD; Sperber BR; Stierstorfer MB; Brod BA; Schleicher SM; Bebo BF; Troxel AB; Shin DB; Steinemann JM; Goldfarb J; Yeung H; Van Voorhees AS
    Arch Dermatol; 2012 Apr; 148(4):487-94. PubMed ID: 22508874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriasis.
    Burfield L; Burden AD
    J R Coll Physicians Edinb; 2013; 43(4):334-8; quiz 339. PubMed ID: 24350319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.
    Garber C; Creighton-Smith M; Sorensen EP; Dumont N; Gottlieb AB
    J Drugs Dermatol; 2015 Aug; 14(8):881-6. PubMed ID: 26267734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of patients with psoriasis.
    Croney S
    Br J Nurs; 2017 Mar; 26(5):260-262. PubMed ID: 28328264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term control of psoriasis is necessary].
    Sánchez Carazo JL; Martínez Casimiro L; Alegre de Miguel V
    Actas Dermosifiliogr; 2008 Jan; 99 Suppl 1():29-36. PubMed ID: 18341851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An attempt to formulate an evidence-based strategy in the management of moderate-to-severe psoriasis: a review of the efficacy and safety of biologics and prebiologic options.
    Leon A; Nguyen A; Letsinger J; Koo J
    Expert Opin Pharmacother; 2007 Apr; 8(5):617-32. PubMed ID: 17376017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
    Bissonnette R; Kerdel F; Naldi L; Papp K; Galindo C; Langholff W; Tang KL; Szapary P; Fakharzadeh S; Srivastava B; Goyal K; Gottlieb AB
    J Drugs Dermatol; 2017 Oct; 16(10):1002-1013. PubMed ID: 29036254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.